Global Mefloquine (CAS 53230-10-7) Market Overview
Western Market Research estimates that the Global Mefloquine (CAS 53230-10-7) Market was valued at USD xxxx units in 2025 and is expected to reach USD xxxx units by 2036, growing at a CAGR of xx% during the forecast period (2026–2036).
Mefloquine is a synthetic antimalarial active pharmaceutical ingredient (API) used primarily for the prevention and treatment of malaria, especially in regions with chloroquine-resistant strains. The market is largely driven by pharmaceutical manufacturing demand, public health procurement programs, and research applications, rather than consumer-led sales.
The Global Mefloquine Market Report 2026 provides a comprehensive evaluation of market sizing, production trends, regulatory influence, competitive positioning, pricing dynamics, and technological advancements. The study combines primary industry interviews with validated secondary sources, enabling robust historical assessment and long-term forecasting through 2036.
Impact of COVID-19 on the Mefloquine Market
The COVID-19 pandemic created short-term volatility in the mefloquine market during 2020 due to manufacturing disruptions, supply chain delays, and shifting public health priorities. API production schedules were affected by raw material shortages and logistics constraints.
However, the market demonstrated resilience as pharmaceutical supply chains normalized and governments resumed essential medicine procurement programs. Post-pandemic, demand has stabilized, supported by ongoing malaria control initiatives and baseline pharmaceutical API requirements.
Global Mefloquine (CAS 53230-10-7) Market Segmentation
By Purity Level
-
≥98% Purity
-
≥99% Purity
-
Research & Analytical Grade
By Application
-
Pharmaceutical Manufacturing
-
Chemical & Analytical Research
-
Contract Research & Development
By Form
-
Powder
-
Crystalline Solid
By End User
-
Pharmaceutical Companies
-
Research Laboratories & CROs
-
Academic & Government Institutions
Regional Analysis
North America
North America represents a stable, research-driven market, supported by pharmaceutical R&D, government stockpiling, and academic research demand in the U.S. and Canada.
Europe
Europe benefits from established pharmaceutical manufacturing standards, regulatory compliance frameworks, and consistent demand for antimalarial APIs, particularly in Germany, the U.K., and France.
Asia-Pacific
Asia-Pacific is the largest and fastest-growing region, driven by cost-efficient API manufacturing, expanding pharmaceutical production capacity, and regional disease management programs in China and India.
South America
Growth is moderate and supported by public health initiatives and regional pharmaceutical production, particularly in Brazil and Argentina.
Middle East & Africa
This region shows strategic importance due to malaria-endemic zones and international health organization procurement, although local manufacturing remains limited.
Key Players in the Global Mefloquine Market
-
Toronto Research Chemicals
-
Alfa Chemistry
-
Waterstone Technology
-
2A PharmaChem
-
Chembest Research Laboratories
-
Ningbo Taikang Chemical
-
Hangzhou J&H Chemical
-
TCI Chemicals
-
LGC Standards
-
Merck KGaA
Porter’s Five Forces Analysis
-
Threat of New Entrants: Low to Moderate – High regulatory and technical barriers
-
Bargaining Power of Suppliers: Moderate – Dependence on specialty chemical intermediates
-
Bargaining Power of Buyers: High – Bulk procurement and strict quality requirements
-
Threat of Substitutes: Low – Limited therapeutic substitutes for specific malaria strains
-
Competitive Rivalry: Moderate – Niche market with specialized manufacturers
SWOT Analysis
Strengths
-
Established therapeutic relevance
-
Well-defined pharmacological profile
-
Consistent institutional demand
Weaknesses
-
Narrow application scope
-
Stringent regulatory compliance costs
Opportunities
-
Expansion of malaria control programs
-
Increased outsourcing of API manufacturing to Asia
-
Demand from research and analytical applications
Threats
-
Emergence of alternative antimalarial therapies
-
Regulatory changes affecting legacy APIs
Trend Analysis
-
Rising focus on high-purity API grades (≥99%)
-
Increased outsourcing to cost-efficient Asian manufacturers
-
Growth in research-grade demand for analytical and formulation studies
-
Emphasis on regulatory traceability and pharmacopoeial compliance
Market Drivers & Challenges
Key Drivers
-
Ongoing global malaria prevention programs
-
Stable pharmaceutical API demand
-
Government and NGO procurement initiatives
Key Challenges
-
Limited market expansion due to therapeutic specificity
-
Regulatory scrutiny and compliance costs
-
Price sensitivity in public-sector procurement
Value Chain Analysis
Raw Chemical Intermediates → API Synthesis → Purification & Quality Control → Regulatory Certification → Pharmaceutical & Research End Users
Value creation is concentrated in high-purity synthesis, documentation, and regulatory compliance.
Strategic Recommendations for Stakeholders
-
API Manufacturers: Focus on high-purity grades and regulatory alignment
-
Pharmaceutical Companies: Secure diversified sourcing to ensure supply continuity
-
Investors: Target niche API producers with strong compliance capabilities
-
Policy & Health Bodies: Support reliable supply chains for essential antimalarial drugs
1. Market Overview of Mefloquine (CAS 53230-10-7)
1.1 Mefloquine (CAS 53230-10-7) Market Overview
1.1.1 Mefloquine (CAS 53230-10-7) Product Scope
1.1.2 Market Status and Outlook
1.2 Mefloquine (CAS 53230-10-7) Market Size by Regions:
1.3 Mefloquine (CAS 53230-10-7) Historic Market Size by Regions
1.4 Mefloquine (CAS 53230-10-7) Forecasted Market Size by Regions
1.5 Covid-19 Impact on Key Regions, Keyword Market Size YoY Growth
1.5.1 North America
1.5.2 East Asia
1.5.3 Europe
1.5.4 South Asia
1.5.5 Southeast Asia
1.5.6 Middle East
1.5.7 Africa
1.5.8 Oceania
1.5.9 South America
1.5.10 Rest of the World
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
2. Covid-19 Impact Mefloquine (CAS 53230-10-7) Sales Market by Type
2.1 Global Mefloquine (CAS 53230-10-7) Historic Market Size by Type
2.2 Global Mefloquine (CAS 53230-10-7) Forecasted Market Size by Type
2.3 Purity 98%
2.4 Purity 99%
2.5 Others
3. Covid-19 Impact Mefloquine (CAS 53230-10-7) Sales Market by Application
3.1 Global Mefloquine (CAS 53230-10-7) Historic Market Size by Application
3.2 Global Mefloquine (CAS 53230-10-7) Forecasted Market Size by Application
3.3 Chemical Industry
3.4 Pharmaceutical Industry
4. Covid-19 Impact Market Competition by Manufacturers
4.1 Global Mefloquine (CAS 53230-10-7) Production Capacity Market Share by Manufacturers
4.2 Global Mefloquine (CAS 53230-10-7) Revenue Market Share by Manufacturers
4.3 Global Mefloquine (CAS 53230-10-7) Average Price by Manufacturers
5. Company Profiles and Key Figures in Mefloquine (CAS 53230-10-7) Business
5.1 Toronto Research Chemicals
5.1.1 Toronto Research Chemicals Company Profile
5.1.2 Toronto Research Chemicals Mefloquine (CAS 53230-10-7) Product Specification
5.1.3 Toronto Research Chemicals Mefloquine (CAS 53230-10-7) Production Capacity, Revenue, Price and Gross Margin
5.2 Alfa Chemistry
5.2.1 Alfa Chemistry Company Profile
5.2.2 Alfa Chemistry Mefloquine (CAS 53230-10-7) Product Specification
5.2.3 Alfa Chemistry Mefloquine (CAS 53230-10-7) Production Capacity, Revenue, Price and Gross Margin
5.3 Waterstone Technology
5.3.1 Waterstone Technology Company Profile
5.3.2 Waterstone Technology Mefloquine (CAS 53230-10-7) Product Specification
5.3.3 Waterstone Technology Mefloquine (CAS 53230-10-7) Production Capacity, Revenue, Price and Gross Margin
5.4 2A PharmaChem
5.4.1 2A PharmaChem Company Profile
5.4.2 2A PharmaChem Mefloquine (CAS 53230-10-7) Product Specification
5.4.3 2A PharmaChem Mefloquine (CAS 53230-10-7) Production Capacity, Revenue, Price and Gross Margin
5.5 3B Scientific
5.5.1 3B Scientific Company Profile
5.5.2 3B Scientific Mefloquine (CAS 53230-10-7) Product Specification
5.5.3 3B Scientific Mefloquine (CAS 53230-10-7) Production Capacity, Revenue, Price and Gross Margin
5.6 Chembest Research Laboratories
5.6.1 Chembest Research Laboratories Company Profile
5.6.2 Chembest Research Laboratories Mefloquine (CAS 53230-10-7) Product Specification
5.6.3 Chembest Research Laboratories Mefloquine (CAS 53230-10-7) Production Capacity, Revenue, Price and Gross Margin
5.7 Ningbo Taikang Chemical
5.7.1 Ningbo Taikang Chemical Company Profile
5.7.2 Ningbo Taikang Chemical Mefloquine (CAS 53230-10-7) Product Specification
5.7.3 Ningbo Taikang Chemical Mefloquine (CAS 53230-10-7) Production Capacity, Revenue, Price and Gross Margin
5.8 Hangzhou J&H Chemical
5.8.1 Hangzhou J&H Chemical Company Profile
5.8.2 Hangzhou J&H Chemical Mefloquine (CAS 53230-10-7) Product Specification
5.8.3 Hangzhou J&H Chemical Mefloquine (CAS 53230-10-7) Production Capacity, Revenue, Price and Gross Margin
5.9 Ningbo Taikang Chemical
5.9.1 Ningbo Taikang Chemical Company Profile
5.9.2 Ningbo Taikang Chemical Mefloquine (CAS 53230-10-7) Product Specification
5.9.3 Ningbo Taikang Chemical Mefloquine (CAS 53230-10-7) Production Capacity, Revenue, Price and Gross Margin
5.10 Advanced Technology & Industrial
5.10.1 Advanced Technology & Industrial Company Profile
5.10.2 Advanced Technology & Industrial Mefloquine (CAS 53230-10-7) Product Specification
5.10.3 Advanced Technology & Industrial Mefloquine (CAS 53230-10-7) Production Capacity, Revenue, Price and Gross Margin
5.11 Application Coverage (Market Size & Forecast
5.11.1 Application Coverage (Market Size & Forecast Company Profile
5.11.2 Application Coverage (Market Size & Forecast Mefloquine (CAS 53230-10-7) Product Specification
5.11.3 Application Coverage (Market Size & Forecast Mefloquine (CAS 53230-10-7) Production Capacity, Revenue, Price and Gross Margin
5.12 Different Demand Market by Region
5.12.1 Different Demand Market by Region Company Profile
5.12.2 Different Demand Market by Region Mefloquine (CAS 53230-10-7) Product Specification
5.12.3 Different Demand Market by Region Mefloquine (CAS 53230-10-7) Production Capacity, Revenue, Price and Gross Margin
5.13 Main Consumer Profile etc.):
5.13.1 Main Consumer Profile etc.): Company Profile
5.13.2 Main Consumer Profile etc.): Mefloquine (CAS 53230-10-7) Product Specification
5.13.3 Main Consumer Profile etc.): Mefloquine (CAS 53230-10-7) Production Capacity, Revenue, Price and Gross Margin
5.14 Chemical Industry
5.14.1 Chemical Industry Company Profile
5.14.2 Chemical Industry Mefloquine (CAS 53230-10-7) Product Specification
5.14.3 Chemical Industry Mefloquine (CAS 53230-10-7) Production Capacity, Revenue, Price and Gross Margin
5.15 Pharmaceutical Industry
5.15.1 Pharmaceutical Industry Company Profile
5.15.2 Pharmaceutical Industry Mefloquine (CAS 53230-10-7) Product Specification
5.15.3 Pharmaceutical Industry Mefloquine (CAS 53230-10-7) Production Capacity, Revenue, Price and Gross Margin
5.16 Region Coverage (Regional Production
5.16.1 Region Coverage (Regional Production Company Profile
5.16.2 Region Coverage (Regional Production Mefloquine (CAS 53230-10-7) Product Specification
5.16.3 Region Coverage (Regional Production Mefloquine (CAS 53230-10-7) Production Capacity, Revenue, Price and Gross Margin
5.17 Demand & Forecast by Countries etc.):
5.17.1 Demand & Forecast by Countries etc.): Company Profile
5.17.2 Demand & Forecast by Countries etc.): Mefloquine (CAS 53230-10-7) Product Specification
5.17.3 Demand & Forecast by Countries etc.): Mefloquine (CAS 53230-10-7) Production Capacity, Revenue, Price and Gross Margin
5.18 North America (U.S.
5.18.1 North America (U.S. Company Profile
5.18.2 North America (U.S. Mefloquine (CAS 53230-10-7) Product Specification
5.18.3 North America (U.S. Mefloquine (CAS 53230-10-7) Production Capacity, Revenue, Price and Gross Margin
5.19 Canada
5.19.1 Canada Company Profile
5.19.2 Canada Mefloquine (CAS 53230-10-7) Product Specification
5.19.3 Canada Mefloquine (CAS 53230-10-7) Production Capacity, Revenue, Price and Gross Margin
5.20 Mexico)
5.20.1 Mexico) Company Profile
5.20.2 Mexico) Mefloquine (CAS 53230-10-7) Product Specification
5.20.3 Mexico) Mefloquine (CAS 53230-10-7) Production Capacity, Revenue, Price and Gross Margin
5.21 Europe (Germany
5.21.1 Europe (Germany Company Profile
5.21.2 Europe (Germany Mefloquine (CAS 53230-10-7) Product Specification
5.21.3 Europe (Germany Mefloquine (CAS 53230-10-7) Production Capacity, Revenue, Price and Gross Margin
5.22 U.K.
5.22.1 U.K. Company Profile
5.22.2 U.K. Mefloquine (CAS 53230-10-7) Product Specification
5.22.3 U.K. Mefloquine (CAS 53230-10-7) Production Capacity, Revenue, Price and Gross Margin
5.23 France
5.23.1 France Company Profile
5.23.2 France Mefloquine (CAS 53230-10-7) Product Specification
5.23.3 France Mefloquine (CAS 53230-10-7) Production Capacity, Revenue, Price and Gross Margin
5.24 Italy
5.24.1 Italy Company Profile
5.24.2 Italy Mefloquine (CAS 53230-10-7) Product Specification
5.24.3 Italy Mefloquine (CAS 53230-10-7) Production Capacity, Revenue, Price and Gross Margin
5.25 Russia
5.25.1 Russia Company Profile
5.25.2 Russia Mefloquine (CAS 53230-10-7) Product Specification
5.25.3 Russia Mefloquine (CAS 53230-10-7) Production Capacity, Revenue, Price and Gross Margin
5.26 Spain etc.)
5.26.1 Spain etc.) Company Profile
5.26.2 Spain etc.) Mefloquine (CAS 53230-10-7) Product Specification
5.26.3 Spain etc.) Mefloquine (CAS 53230-10-7) Production Capacity, Revenue, Price and Gross Margin
5.27 Asia-Pacific (China
5.27.1 Asia-Pacific (China Company Profile
5.27.2 Asia-Pacific (China Mefloquine (CAS 53230-10-7) Product Specification
5.27.3 Asia-Pacific (China Mefloquine (CAS 53230-10-7) Production Capacity, Revenue, Price and Gross Margin
5.28 India
5.28.1 India Company Profile
5.28.2 India Mefloquine (CAS 53230-10-7) Product Specification
5.28.3 India Mefloquine (CAS 53230-10-7) Production Capacity, Revenue, Price and Gross Margin
5.29 Japan
5.29.1 Japan Company Profile
5.29.2 Japan Mefloquine (CAS 53230-10-7) Product Specification
5.29.3 Japan Mefloquine (CAS 53230-10-7) Production Capacity, Revenue, Price and Gross Margin
5.30 Southeast Asia etc.)
5.30.1 Southeast Asia etc.) Company Profile
5.30.2 Southeast Asia etc.) Mefloquine (CAS 53230-10-7) Product Specification
5.30.3 Southeast Asia etc.) Mefloquine (CAS 53230-10-7) Production Capacity, Revenue, Price and Gross Margin
5.31 South America (Brazil
5.31.1 South America (Brazil Company Profile
5.31.2 South America (Brazil Mefloquine (CAS 53230-10-7) Product Specification
5.31.3 South America (Brazil Mefloquine (CAS 53230-10-7) Production Capacity, Revenue, Price and Gross Margin
5.32 Argentina etc.)
5.32.1 Argentina etc.) Company Profile
5.32.2 Argentina etc.) Mefloquine (CAS 53230-10-7) Product Specification
5.32.3 Argentina etc.) Mefloquine (CAS 53230-10-7) Production Capacity, Revenue, Price and Gross Margin
6. North America
6.1 North America Mefloquine (CAS 53230-10-7) Market Size
6.2 North America Mefloquine (CAS 53230-10-7) Key Players in North America
6.3 North America Mefloquine (CAS 53230-10-7) Market Size by Type
6.4 North America Mefloquine (CAS 53230-10-7) Market Size by Application
7. East Asia
7.1 East Asia Mefloquine (CAS 53230-10-7) Market Size
7.2 East Asia Mefloquine (CAS 53230-10-7) Key Players in North America
7.3 East Asia Mefloquine (CAS 53230-10-7) Market Size by Type
7.4 East Asia Mefloquine (CAS 53230-10-7) Market Size by Application
8. Europe
8.1 Europe Mefloquine (CAS 53230-10-7) Market Size
8.2 Europe Mefloquine (CAS 53230-10-7) Key Players in North America
8.3 Europe Mefloquine (CAS 53230-10-7) Market Size by Type
8.4 Europe Mefloquine (CAS 53230-10-7) Market Size by Application
9. South Asia
9.1 South Asia Mefloquine (CAS 53230-10-7) Market Size
9.2 South Asia Mefloquine (CAS 53230-10-7) Key Players in North America
9.3 South Asia Mefloquine (CAS 53230-10-7) Market Size by Type
9.4 South Asia Mefloquine (CAS 53230-10-7) Market Size by Application
10. Southeast Asia
10.1 Southeast Asia Mefloquine (CAS 53230-10-7) Market Size
10.2 Southeast Asia Mefloquine (CAS 53230-10-7) Key Players in North America
10.3 Southeast Asia Mefloquine (CAS 53230-10-7) Market Size by Type
10.4 Southeast Asia Mefloquine (CAS 53230-10-7) Market Size by Application
11. Middle East
11.1 Middle East Mefloquine (CAS 53230-10-7) Market Size
11.2 Middle East Mefloquine (CAS 53230-10-7) Key Players in North America
11.3 Middle East Mefloquine (CAS 53230-10-7) Market Size by Type
11.4 Middle East Mefloquine (CAS 53230-10-7) Market Size by Application
12. Africa
12.1 Africa Mefloquine (CAS 53230-10-7) Market Size
12.2 Africa Mefloquine (CAS 53230-10-7) Key Players in North America
12.3 Africa Mefloquine (CAS 53230-10-7) Market Size by Type
12.4 Africa Mefloquine (CAS 53230-10-7) Market Size by Application
13. Oceania
13.1 Oceania Mefloquine (CAS 53230-10-7) Market Size
13.2 Oceania Mefloquine (CAS 53230-10-7) Key Players in North America
13.3 Oceania Mefloquine (CAS 53230-10-7) Market Size by Type
13.4 Oceania Mefloquine (CAS 53230-10-7) Market Size by Application
14. South America
14.1 South America Mefloquine (CAS 53230-10-7) Market Size
14.2 South America Mefloquine (CAS 53230-10-7) Key Players in North America
14.3 South America Mefloquine (CAS 53230-10-7) Market Size by Type
14.4 South America Mefloquine (CAS 53230-10-7) Market Size by Application
15. Rest of the World
15.1 Rest of the World Mefloquine (CAS 53230-10-7) Market Size
15.2 Rest of the World Mefloquine (CAS 53230-10-7) Key Players in North America
15.3 Rest of the World Mefloquine (CAS 53230-10-7) Market Size by Type
15.4 Rest of the World Mefloquine (CAS 53230-10-7) Market Size by Application
16 Mefloquine (CAS 53230-10-7) Market Dynamics
16.1 Covid-19 Impact Market Top Trends
16.2 Covid-19 Impact Market Drivers
16.3 Covid-19 Impact Market Challenges
16.4 Porter
Global Mefloquine (CAS 53230-10-7) Market Segmentation
By Purity Level
-
≥98% Purity
-
≥99% Purity
-
Research & Analytical Grade
By Application
-
Pharmaceutical Manufacturing
-
Chemical & Analytical Research
-
Contract Research & Development
By Form
-
Powder
-
Crystalline Solid
By End User
-
Pharmaceutical Companies
-
Research Laboratories & CROs
-
Academic & Government Institutions
Regional Analysis
North America
North America represents a stable, research-driven market, supported by pharmaceutical R&D, government stockpiling, and academic research demand in the U.S. and Canada.
Europe
Europe benefits from established pharmaceutical manufacturing standards, regulatory compliance frameworks, and consistent demand for antimalarial APIs, particularly in Germany, the U.K., and France.
Asia-Pacific
Asia-Pacific is the largest and fastest-growing region, driven by cost-efficient API manufacturing, expanding pharmaceutical production capacity, and regional disease management programs in China and India.
South America
Growth is moderate and supported by public health initiatives and regional pharmaceutical production, particularly in Brazil and Argentina.
Middle East & Africa
This region shows strategic importance due to malaria-endemic zones and international health organization procurement, although local manufacturing remains limited.
Key Players in the Global Mefloquine Market
-
Toronto Research Chemicals
-
Alfa Chemistry
-
Waterstone Technology
-
2A PharmaChem
-
Chembest Research Laboratories
-
Ningbo Taikang Chemical
-
Hangzhou J&H Chemical
-
TCI Chemicals
-
LGC Standards
-
Merck KGaA
